Global Digital Therapeutics Market Analysis 2016-2026 - Market is Expected to Reach $8,379.32 Million by 2026 -

DUBLIN--()--The "Global Digital Therapeutics Market Analysis 2019" report has been added to's offering.

The Global Digital Therapeutics market is expected to reach $8,379.32 million by 2026 growing at a CAGR of 19.0% during the forecast period.

Key Questions Answered in this Report:

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period.

Factors driving the market are a rapid increase in technological advancements and increasing incidence of preventable chronic diseases. However, resistance from traditional healthcare providers and concerns of patient data privacy are hampering the market growth.

Based on the application, the diabetes segment is estimated to grow significantly during the forecast period due to its high incidence and prevalence. A large number of practitioners are using mhealth for effective management coaching to handle symptoms like polyuria, polydipsia, and polyphagia which makes the segment growth in the upcoming years.

The key vendors mentioned are:

  • Omada Health, Inc.
  • Noom Inc.
  • Proteus Digital Health, Inc.
  • Welldoc, Inc.
  • Ginger.Io, Inc.
  • Livongo Health
  • 2morrow Inc.
  • Mango Health Inc.
  • Propeller Health
  • Canary Health Inc.
  • Medtronic Plc

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Digital Therapeutics Market, By Product

5.1 Introduction

5.2 Software

5.3 Devices

6 Global Digital Therapeutics Market, By Application

6.1 Introduction

6.2 Obesity

6.3 Central Nervous System (CNS) Diseases

6.4 Diabetes

6.5 Gastrointestinal Disorder (GID)

6.6 Mental Health

6.7 Cardiovascular Diseases

6.8 Smoking Cessation

6.9 Respiratory Diseases

6.10 Ophthalmology

6.11 Musculoskeletal Disorders

6.12 Medication Adherence

6.13 Neurology

6.14 Other Applications

7 Global Digital Therapeutics Market, By End User

7.1 Introduction

7.2 Providers

7.3 Payers

7.4 Patients

7.5 Employers

7.6 Pharmaceutical Companies

7.7 Health Providers

7.8 Other End Users

8 Global Digital Therapeutics Market, By Geography

8.1 Introduction

8.2 North America

8.3 Europe

8.4 Asia Pacifc

8.5 South America

8.6 Middle East & Africa

9 Strategic Benchmarking

10 Vendors Landscape

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900